Lopez-Velez R, Batlle C, Jiménez C, Navarro M, Norman F, Perez-Molina J.

Short course combination therapy for giardiasis after nitroimidazole failure.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 2010. 83(1): 171-173. Nº de citas: 31

[doi:10.4269/ajtmh.2010.09-0742]

Arnáez J, Roa MA, Albert L, Cogollos R, Rubio JM, Villares R, Alarabe A, Cervera A, López-Vélez R.

Imported malaria in children: a comparative study between recent immigrants and immigrant travelers (VFRs).

JOURNAL OF TRAVEL MEDICINE 2010. 17(4): 221-227. Nº de citas: 32

[doi:10.1111/j.1708-8305.2010.00416.x]

Poveda E, Anta L, Blanco JL, Casado JL, Gutiérrez F, García F, Gómez-Sirvent JL, Iribarren JA, Soriano V, de Mendoza C.

Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2010. 54(7): 3018-3020. Nº de citas: 8

[doi:10.1128/AAC.00160-10]

Poveda E, Alcamí J, Paredes R, Córdoba J, Gutiérrez F, Llibre JM, Delgado R, Pulido F, Iribarren JA, García Deltoro M, Hernández Quero J, Moreno S, García F.

Genotypic Determination of HIV Tropism - Clinical and Methodological Recommendations to Guide the Therapeutic Use of CCR5 Antagonists

AIDS REVIEWS 2010. 12(3): 135-148. Nº de citas: 43

Patier de La Peña JL, Norman F, Rodríguez-Ramírez GI, Echániz-Quintana A, Moreno-Cobo MA.

Cervicalgia, tortícolis y poliglobulia como forma de presentación de un hemangioblastoma cerebeloso.

REVISTA CLINICA ESPANOLA 2010. 210(6): .

[doi:10.1016/j.rce.2010.03.001]

Moreno S, López Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, Rivero A, Pulido F.

The future of antiretroviral therapy: challenges and needs

The Journal of antimicrobial chemotherapy 2010. 65(5): 827-835. Nº de citas: 38

[doi:10.1093/jac/dkq061]

Gutiérrez-Cisneros MJ, Cogollos R, López-Vélez R, Martín-Rabadán P, Martínez-Ruiz R, Subirats M, Merino FJ, Fuentes I.

Application of real-time PCR for the differentiation of Entamoeba histolytica and E. dispar in cyst-positive faecal samples from 130 immigrants living in Spain.

ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY 2010. 104(2): 145-149. Nº de citas: 23

[doi:10.1179/136485910X12607012373759]

Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BY, BENCHMRK Study Teamsa.

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.

CLINICAL INFECTIOUS DISEASES 2010. 50(4): 605-612. Nº de citas: 172

[doi:10.1086/650002]

Navas Elorza E, Moreno Guillén S.

Tuberculosis multirresistente y extremadamente resistente.

Revista española de sanidad penitenciaria 2010. 12(3): 91-98.

[doi:10.4321/S1575-06202010000300005]

Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C.

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.

AIDS 2010. 24(3): 469-471. Nº de citas: 13

[doi:10.1097/QAD.0b013e328331a4b8]

Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA.

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

AIDS 2010. 24(1): 123-137. Nº de citas: 287

[doi:10.1097/QAD.0b013e3283324283]

Fortún J.

LETTER TO THE EDITOR: Response to the Letter by Dr. Julio Collazos.

The open respiratory medicine journal 2010. 4: 17-17.

[doi:10.2174/1874306401004010017]

Moreno S, Mocroft A, Monforte Ad.

Medical and societal consequences of late presentation

ANTIVIRAL THERAPY 2010. 15(1): 9-15. Nº de citas: 56

[doi:10.3851/IMP1523]

Antinori A, Johnson M, Moreno S, Yazdanpanah Y, Rockstroh JK.

Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation

ANTIVIRAL THERAPY 2010. 15(1): 31-35. Nº de citas: 23

[doi:10.3851/IMP1525]

Ghosn J, Carosi G, Moreno S, Pokrovsky V, Lazzarin A, Pialoux G, Sanz-Moreno J, Balogh A, Vandeloise E, Biguenet S, Leleu G, Delfraissy JF.

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

ANTIVIRAL THERAPY 2010. 15(7): 993-1002. Nº de citas: 33

[doi:10.3851/IMP1666]

Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Pérez-Alvarez L, Pumarola T, López-Lirola A, González-García J, Menéndez-Arias L.

HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.

The Journal of antimicrobial chemotherapy 2009. 64(2): 251-258. Nº de citas: 11

[doi:10.1093/jac/dkp200]

Pérez Cachafeiro S, Del Amo J, Iribarren JA, Salavert Lleti M, Gutiérrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, Moreno S.

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

CLINICAL INFECTIOUS DISEASES 2009. 48(10): 1467-1470. Nº de citas: 52

[doi:10.1086/598333]

Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, del Amo J, Moreno S, CoRIS.

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.

CURRENT HIV RESEARCH 2009. 7(2): 224-230. Nº de citas: 88

[doi:10.2174/157016209787581535]